Brief: HLS Therapeutics Announces Fiscal 2017 Financial Results
29/03/2018 11:40
March 29 (Reuters) - HLS Therapeutics Inc HLS.V :
* HLS THERAPEUTICS ANNOUNCES FISCAL 2017 FINANCIAL RESULTS
* HLS THERAPEUTICS INC - TOTAL REVENUE FOR THREE-MONTH
PERIOD
ENDED DECEMBER 31, 2017 WAS $20.4 MILLION COMPARED TO $15.8
MILLION
Source text for Eikon: ID:nCNWZ5hxza
Further company coverage: HLS.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HLS Therapeutics
See all newsCanada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group
Canada's HLS Therapeutics Q1 revenue rises on Vascepa growth, reaffirms 2026 guidance
Canada's HLS Therapeutics Q4 revenue slightly beats on Vascepa strength
Brief: Esperion Partner announces HLS Therapeutics received approval Of NILEMDO for the reduction of LDL-cholesterol in canadians at risk of cardiovascular disease
Brief: HLS Therapeutics announces Health Canada approval of NILEMDO for the reduction of LDL-Cholesterol in Canadians at risk of cardiovascular disease